Description
Pemigatinib (INCB054828) is an orally active, selective inhibitor of FGFR, with IC50 values of 0.4 nM for FGFR1, 0.5 nM for FGFR2, 1.2 nM for FGFR3, and 30 nM for FGFR4.
Molecular Formula
C24H27F2N5O4
Smiles
CCN1C(=O)N(CC2C[NH]C3NC(CN4CCOCC4)CC3C12)C1C(F)C(OC)CC(OC)C1F
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Solubility Information
DMSO: 4.88 mg/mL (10 mM), Sonication is recommended.10% DMSO+90% Saline: 0.1 mg/mL (0.21 mM), In vivo: Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately.
Relative Density
1.44 (Predicted)